OFF-LABEL DRUG USES SHOULD BE ADDRESSED IN PATIENT DRUG INFORMATION LEAFLETS, CONFEREES TELL FDA; STANDARD FORMAT RETAINING FLEXIBILITY RECOMMENDED
Executive Summary
Patient drug information leaflets should include information on off-label uses, breakout session participants urged at a Feb. 14-15 FDA Patient Drug Information "Medguide" workshop held in Rockville, Md.